Abstract
Introduction
Of all the cancers treated by Head & Neck oncologists, malignant salivary gland tumours are arguably the most difficult. Patients are not infrequently young and the cure rates are very poor for most histological types. Why malignant salivary neoplasms and adenoid cystic carcinoma, in particular, are so resistant to treatment is not known even with the twenty first century explosion in the techniques of molecular biology. The natural history of the cancers tends to be long and patient may under go multiple treatments in attempt to control their disease at least 1 .
According to Batsakis et al. 2 , The incidence of primary SCC of the salivary glands is some where between 0.3% &1.5%. Squamous cell carcinoma (SCC) involving the salivary gland is much more common and, to be defind as a salivary carcinoma, certain criteria must be met. The tumour must arise 1 nodes. After wound healing he was treated by radiotherapy. On follow up visits, the patient stated that he was satisfied with the results but a small upper eyelid swelling was seen and advised for excision and to continue the treatment (therapy).
Discussion
Most authors suggest that one in six parotid tumours are malignant. Not all of the oncologist agree with this rather a much higher figure of one in four or even one in three has been quoted. According to Liverpool head neck data base, 24% of all parotid tumours are malignant tumours of the main body. Malignant tumour may enlarge rapidly and facial nerve paralysis is not uncommon. Facial nerve paralysis as a presenting sign appears in approximately one third of patients.
Pain is a symtom of malignancy. Carcinoma of the deep lobe expand medially in to pharynx. Although about 10% of parotid tumours are from the deep lobe, fortunately malignancy is fairly unusual at this site. The commonest malignancy is the mucoepidermoid carcinoma followed by adenoid cystic carcinoma. It should be remembered that the parotid gland contains lymph nodes, superficial lobe contain 3 to 7, and deep lobe contain 0 to 3 nodes. Regional nodal involvement is seen approximately in 13% of parotid cancers but the risk of recurrence in a previously involved neck is greater than 50%. Owing to these findings, either a selective neck dissection clearing area 1, 2 and 3 or even a radical neck dissection in high grade tumours should probably be carried out. Post operative irradiation almost certainly improves loco regional control, although these are no randomized trials to support this view.
Conclusion
As synchronous malignancy of parotid gland, eyeball with metastatic neck nodes is rare, so this case has been selected to publish in the medical journal.
